Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:antibiotic
|
| gptkbp:administeredBy |
intramuscular injection
intravenous injection |
| gptkbp:ATCCode |
gptkb:J01CF04
|
| gptkbp:CASNumber |
66-79-5
|
| gptkbp:chemicalFormula |
C19H19N3O5S
|
| gptkbp:developedBy |
gptkb:Beecham
|
| gptkbp:discoveredIn |
1960
|
| gptkbp:eliminationHalfLife |
0.5 to 1 hour
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:isomerOf |
gptkb:cloxacillin
gptkb:dicloxacillin gptkb:flucloxacillin |
| gptkbp:KEGGID |
gptkb:D08304
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits bacterial cell wall synthesis
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
401.44 g/mol
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:PubChem_CID |
gptkb:DB00713
CHEMBL1377 6196 |
| gptkbp:resistantTo |
gptkb:penicillinase
|
| gptkbp:sideEffect |
diarrhea
allergic reaction rash liver dysfunction |
| gptkbp:UNII |
4OR63N9945
|
| gptkbp:usedFor |
treatment of staphylococcal infections
|
| gptkbp:bfsParent |
gptkb:MSSA
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
oxacillin
|